Methyl 2-(bromomethyl)-3-nitrobenzoate98475-07-1 CAS NO.98475-07-1

Min.Order Quantity:: 1 Kilogram

Purity:: 98%min

Port:: Wuhan

Payment Terms:: L/C,D/A,D/P,T/T,MoneyGram,Other

Add to Inquiry Cart

Product Details

Keywords

Lenalidomide intermediate
Lenalidomide supplier
low price Lenalidomide intermediate

Quick Details

ProName: Methyl 2-(bromomethyl)-3-nitrobenzoate...
CasNo: 98475-07-1
Molecular Formula: C9H8BrNO4
Appearance: solid
Application: Lenalidomide intermediate
DeliveryTime: within 1 week
PackAge: 1kg/package, 5kg/package
Port: Wuhan
ProductionCapacity: 10 Kilogram/Month
Purity: 98%min
Storage: Store in dry place. Avoid Moisture.tig...
Transportation: by air
LimitNum: 1 Kilogram
Moisture Content: 1.0%max
Impurity: 0.5%max

Superiority

this is one of our most competitive pharmaceutical intermediates.

identification: h-nmr

purity：98%min

package: 500g/bag, 1kg/bag

we can also arrange contract production for r&d to commerical quantities.

we can offer tdp package for documents support .

we can offer lenalidomide api and intermediates:

lenalidomide	191732-72-6
methyl 2-bromomethyl-3-nitrobenzoate	98475-07-1
2,6-dioxopiperidine-3-ammonium chloride	24666-56-6

Details

company profile:

wuhan sunrise technology development company limited(wuhan sunrise pharmaceutical tehcnology co., ltd) wuhan sunrise technology development company limited is a high-tech pharmaceutical enterprise dedicated to r&d of chemical drug. the main business are r&d, technology transfer and technical services of apis and pharmaceutical intermediates; r&d, manufacture and sales of pis. moreover, we have the right of dealing self-managed imp & exp business.

main products:

chemical synthesis series：
anti-cancer pharmaceutical intermediates，
ophthalmology apis and related intermediates
biological series: mabs